Abinanthan@kbin.social to

Science@kbin.social · 2 years ago

Drug donanemab seen as turning point in dementia fight

1

0

Drug donanemab seen as turning point in dementia fight

Abinanthan@kbin.social to

Science@kbin.social · 2 years ago

1

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

You must log in or register to comment.

Chat

claustrum@kbin.social
link
fedilink
arrow-up
1·
edit-2
2 years ago
For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)

Science@kbin.social

science@kbin.social

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !science@kbin.social

This magazine is dedicated to discussions on scientific discoveries, research, and theories across various fields, including physics, chemistry, biology, astronomy, and more. Whether you are a scientist, a science enthusiast, or simply curious about the world around us, this is the place for you. Here you can share your knowledge, ask questions, and engage in discussions on a wide range of scientific topics. From the latest breakthroughs to historical discoveries and ongoing research, this category covers a wide range of topics related to science.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

7 users / day
1 user / week
8 users / month
13 users / 6 months
74 local subscribers
76 subscribers
375 Posts
689 Comments
Modlog

mods: